Effect of Genetic Differences in Omeprazole Metabolism on Cure Rates for Helicobacter pylori Infection and Peptic Ulcer
Article Abstract:
Many patients with Helicobacter pylori infection may have different cure rates depending on genetic differences in the enzyme S-mephenytoin 4'-hydroxylase (CYP2C19). This liver enzyme metabolizes the drug omeprazole, which is used to treat Helicobacter pylori infection. Helicobacter pylori infection has been linked to peptic ulcer. In a study of 62 Japanese patients with Helicobacter pylori infection, those who metabolized omeprazole quickly had a 28% cure rate, those who metabolized the drug more slowly had a 60% cure rate and those who metabolized the drug the slowest had a 100% cure rate. Their ulcers healed at similar rates.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Combination treatment for peptic ulcers at high risk for recurrent bleeding
Article Abstract:
Endoscopic treatment combined with the proton pump inhibitor omeprazole is more effective for preventing recurrent peptic ulcer bleeding in patients with a high risk of recurrent bleeding than omeprazole alone, according to a study of 156 patients. Risk factors for recurrent bleeding include visible blood vessels during endoscopy or a blood clot on a blood vessel. Endoscopic treatment involves using a heat probe to seal a bleeding blood vessel.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Treatment of patients at high risk for recurrent bleeding from a peptic ulcer
Article Abstract:
Patients who have a peptic ulcer that has bled in the past should be treated with thermal coagulation and an intravenous proton pump inhibitor such as omeprazole if endoscopy detects visible blood vessels or a blood clot on a blood vessel. Thermal coagulation can be delivered via endoscopy. The combined treatment may be more effective than proton pump inhibitors alone.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Virucides in prevention of HIV infection: research priorities. Genomic homogeneity of the AHU/IA-1,2 phenotype of Neisseria gonorrhoeae during its disappearance from an urban population
- Abstracts: Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet
- Abstracts: Withdrawal syndrome. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
- Abstracts: Brian Belle-Fortune a voice from acute nursing. Providing care at home for cardiac surgery patients. Cardiac rehabilitation services: are the provided equitably?
- Abstracts: Management of patients undergoing percutaneous coronary revascularization. Management of patients undergoing percutaneous coronary interventions